Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Importance Treatment of Crohn disease is rapidly evolving, with the induction of novel
biologic therapies and newer, often more intensive treatment approaches. Knowing how to …

Background The efficacy of vedolizumab, an α4β7 integrin antibody, in Crohn's disease is
unknown. Methods In an integrated study with separate induction and maintenance trials …

Background & Aims Little is known about the long-term efficacy of infliximab for patients with
fistulizing perianal Crohn's disease. We evaluated outcomes and predictors of outcomes in …

我国炎症性肠病诊断与治疗的共识意见(2012年·广州)-[维普官方网站]-www.cqvip.com-维普网
我的维普 购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线 …

The concept of fecal microbiota transplantation (FMT) has been used in traditional Chinese
medicine at least since the 4 th century. Evidence from recent human studies strongly …

Exclusive enteral nutrition (EEN) is well-established as a first line therapy instead of
corticosteroid (CS) therapy to treat active Crohn's disease (CD) in children. It also has been …

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that causes significant
morbidity and represents a considerable burden to society and the health care system. 1–5 …

Background Recent evidence suggests that embryonated eggs of the porcine whipworm T
richuris suis ova (TSO) may be an effective treatment for inflammatory bowel disease (IBD) …

Introduction Variation in adherence to management guidelines for inflammatory bowel
disease (IBD) suggests variable quality of care. Quality indicators (QIs) can be developed to …